TARA Biosystems
New York
About TARA Biosystems
Tara Biosystems provides predictive, in vitro human cardiac tissue models for use in drug discovery, safety assessment and translational medicine. Tara Biosystems offers a high-fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The company is dedicated to pioneering predictive cardiac tissue models that enable the faster, safer, and more reliable development of new medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $21.2M
- Funding stage: M&A
- Last round: Series A (Nov 2021)
- Website: tarabiosystems.com
- Phone: 12125820900
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/tara-biosystems-105575 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.